Skip to content

Exploring the influence of vigilance state on MEP amplitude induced by TMS

Exploring the influence of vigilance state on MEP amplitude induced by TMS - Vigilance state and MEP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42077
Enrollment
55
Registered
2015-03-09
Start date
2015-01-15
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovasculair accident (CVA) en myelopathie impaired motor nerve conductivity stroke

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All participants must be over 18 years old and give informed consent Healthy participants: (perceived) healthy Stroke patients: first ever stroke, stroke must have occurred more than 72 hours but less than one week prior to measurement Myelopathy patients: radiological evidence of spinal cord compression on MRI above the level of C8

Exclusion criteria

Exclusion criteria: All participants: Medication influencing cortical excitability (except stroke patients), presence of metals in the head, presence of electronic implants, (suspected) history of epilepsy, history of severe cerebral trauma, (possible) pregnancy Stroke patients: aphasia, presence of cardiac lines

Design outcomes

Primary

MeasureTime frame
Variance in intraindividual MEP amplitude.

Secondary

MeasureTime frame
N.A.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)